RxDoctor Payments Data

Alan Wimmer, MD

Clinical Cardiac Electrophysiology · Kansas City, MONPI 1891866018

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $12,500 of the $17,708 with a category attached, or 70.6%. Boston Scientific accounts for 79.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $6,390 and has fallen 90.6% since, to $603 in 2025.

$17,708in general payments, 2019–2025

Across 51 payments — averaging $347.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$14K
  • Medtronic$2K
  • Abbott$449
  • Irhythm Technologies, Inc.$263
  • Biotronik Inc.$152
  • Siemens Medical Solutions USA, Inc.$144
  • plus $185 from 2 others
$470,972in research payments, 2019–2025

Across 150 payments — averaging $3139.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$253K
  • Medical Device Business Services, Inc.$124K
  • Atricure, Inc.$81K
  • Abbott$14K

What the payments were for

  • Speaking & faculty fees$12,50071%
  • Travel & lodging$1,98811%
  • Food & beverage$3,20618%
  • Education$140%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,708 in reported general payments places this provider in the 55th percentile of 74 clinical cardiac electrophysiology providers in Missouri.

See all clinical cardiac electrophysiology providers in Missouri

Medicare billing

Part B allowed, 2024
$270,731
Medicare patients
1,667
Services billed
3,804

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban394$420,870
XareltoRivaroxaban58$66,596
EntrestoSacubitril/Valsartan29$49,101
MultaqDronedarone Hcl23$41,607
JardianceEmpagliflozin21$28,919
Dofetilide69$24,952
Flecainide Acetate154$8,509
Repatha SureclickEvolocumab11$5,911
Diltiazem 24hr Er (Cd)Diltiazem Hcl136$4,263
Metoprolol Succinate241$2,690
Amiodarone Hcl36$1,543
Eplerenone23$1,512
Carvedilol117$1,170
Rosuvastatin Calcium39$997
Losartan Potassium84$992

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →